Enabling clinical, translational research, population genomics, and biopharma customer markets SAN DIEGO– Illumina, Inc. is enhancing its capabilities to analyze and interpret the data produced by its sequencing systems with the acquisition of BlueBee, a cloud-based software company that provides genomics analysis solutions for research and clinical customers. Based in the Netherlands, BlueBee has developed […]
Enhanced Search for Non-Coding Variants in Mastermind Genomic Search Engine Solves Industry-Wide Challenge Genomenon’s latest release of the Mastermind® Genomic Search Engine includes enhanced search for intronic and non-coding variants across the medical literature. Mastermind users now receive more specific results when searching the comprehensive database of genomic evidence. Intronic and non-coding variants are notoriously difficult for geneticists and […]
Leading enterprise software will integrate digital innovation efforts at Servier by automating data workflows and enabling R&D collaborators to benefit from scientific data integration and harmonization Basel, Switzerland – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that leading French biopharmaceutical company Laboratoires Servier has selected Genedata Screener® as part of […]
Project Will Evolve Data Sharing Paradigm with the Goal of Rapidly Bringing Data from ongoing Clinical Trials to the Research Community BOSTON, MANHATTAN BEACH, CALIF. – Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced that it has been selected by the Pancreatic Cancer Action Network (PanCAN) to build a customized, integrated health data platform […]
Auckland, NZ – Boston-based antibody discovery services company Abveris has partnered with Biomatters to incorporate the Geneious Biologics data analysis platform into their antibody discovery workflow. In collaboration, a new Single Clone Antibody Annotator pipeline has been developed. With a rapidly growing customer base and a wide range of antibody discovery services, Abveris plans to […]
The highly requested and long-awaited interaction search is finally here! Given the great amount of structural data we have at hand, the ability to mine ligand-protein complexes based on the interactions they create was a missing piece in our analytics toolbox. The scientific applications of this new feature are numerous: Idea generation: finding new chemical […]
The Seven Bridges Bioinformatics Ecosystem Supports the Critical Turnaround Times for the CareDx AlloSure® 3.0 Workflow BOSTON—Seven Bridges, the industry-leading bioinformatics ecosystem provider, announced today a new partnership with CareDx, Inc. (Nasdaq: CDNA) supporting the CareDx AlloSure 3.0 workflow. CareDx is a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value […]
BOSTON—Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced the successful completion of independent examinations for SOC 2 Type 2, SOC 3 and HIPAA. The examinations were conducted by independent service auditor Schellman and Company, LLC. These additions to the Seven Bridges compliance portfolio complement the company’s existing ISO 27001, ISO 27017, ISO 27018 and […]
Leading Japanese solution provider for drug discovery extends use of automated screening data analysis platform to expand their offering of drug discovery screening with innovative screening technologies Tokyo, Japan – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that leading Japanese solution provider in the drug discovery space Axcelead Drug […]
Cambridge, UK – Genestack Ltd. today announced that its flagship multi-omics data catalogue, curation and integrative search product, Omics Data Manager (ODM), has been licensed and implemented by AstraZeneca. Genestack’s ODM is an enabling technology providing a central hub for organising and querying multi-omics data from multiple sites, including transcriptomics and proteomics. Curation tools, such as ODM, will enable AstraZeneca […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
